Launching stakeholder discussions on identified regulatory needs for nanotechnology-enabled health products
The development of nanotechnology-enabled health products offers innovative therapeutic and diagnostic opportunities to address medical needs. At the moment, no specific regulatory framework exists for such products since they can be covered by the existing frameworks for medicinal products and medi...
Gorde:
| Egile Nagusiak: | , , , , , , , , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Andover House Inc.
2020-06-01
|
| Saila: | Precision Nanomedicine |
| Sarrera elektronikoa: | https://doi.org/10.33218/001c.13521 |
| Etiketak: |
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|